- Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)2019 | Third Faculty of Medicine
- Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)2021 | Third Faculty of Medicine
- Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma2011 | Third Faculty of Medicine
- High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party2018 | Publication without faculty affiliation
- Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group2011 | Third Faculty of Medicine
- Reduction of toxicity in first-line treatment of advanced stage Hodgkin lymphoma2011 | Third Faculty of Medicine
- Prognostic impact of bone involvement in Hodgkin lymphoma2008 | First Faculty of Medicine, Third Faculty of Medicine
- Echocardiographic evaluation of acute cardiotoxicity in the Treatment of Hodgkin's disease according to the German Hodgkin's Lymphoma Study Group2002 | Third Faculty of Medicine